| abstract |
The invention discloses a production process of mesalazine oral liquid. The mesalamine oral liquid is prepared from the following raw materials in parts by weight: 10-20 parts of mesalazine, 5-8 parts of Scutellaria baicalensis extract, and 5- parts of Coptis chinensis extract. 8 parts, 5-8 parts of Poria cocos extract, 10-15 parts of fresh yam, 1.5-2 parts of citric acid, 3-5 parts of stevia, 20-30 parts of deionized water; The ratio of the extract and the Poria cocos extract makes the prepared oral liquid more effective and efficient in treating ulcerative colitis. Coptis chinensis and Scutellaria baicalensis have good liver protection effects, thereby preventing the prolonged use of mesalazine. After oral liquid, the liver is damaged. The use of citric acid and stevia makes mesalazine oral liquid taste better, and no sucrose is added, so that patients with diabetes can also take mesalazine oral liquid for treatment, which greatly increases the application range, which is more conducive to market promotion. |